JP2010507388A5 - - Google Patents

Download PDF

Info

Publication number
JP2010507388A5
JP2010507388A5 JP2009534057A JP2009534057A JP2010507388A5 JP 2010507388 A5 JP2010507388 A5 JP 2010507388A5 JP 2009534057 A JP2009534057 A JP 2009534057A JP 2009534057 A JP2009534057 A JP 2009534057A JP 2010507388 A5 JP2010507388 A5 JP 2010507388A5
Authority
JP
Japan
Prior art keywords
prostate cancer
marker
allele
diagnosed
polymorphic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009534057A
Other languages
English (en)
Japanese (ja)
Other versions
JP5631000B2 (ja
JP2010507388A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IS2007/000019 external-priority patent/WO2008050356A1/en
Publication of JP2010507388A publication Critical patent/JP2010507388A/ja
Publication of JP2010507388A5 publication Critical patent/JP2010507388A5/ja
Application granted granted Critical
Publication of JP5631000B2 publication Critical patent/JP5631000B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009534057A 2006-10-27 2007-10-26 Chr8q24.21上の癌感受性変異体 Expired - Fee Related JP5631000B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IS8560 2006-10-27
IS8560 2006-10-27
PCT/IS2007/000019 WO2008050356A1 (en) 2006-10-27 2007-10-26 Cancer susceptibility variants on chr8q24.21

Publications (3)

Publication Number Publication Date
JP2010507388A JP2010507388A (ja) 2010-03-11
JP2010507388A5 true JP2010507388A5 (enExample) 2011-01-27
JP5631000B2 JP5631000B2 (ja) 2014-11-26

Family

ID=39060300

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009534057A Expired - Fee Related JP5631000B2 (ja) 2006-10-27 2007-10-26 Chr8q24.21上の癌感受性変異体

Country Status (13)

Country Link
US (1) US20100129799A1 (enExample)
EP (1) EP2089548A1 (enExample)
JP (1) JP5631000B2 (enExample)
CN (1) CN101641451A (enExample)
AU (1) AU2007310412B2 (enExample)
BR (1) BRPI0718322A2 (enExample)
CA (1) CA2667737A1 (enExample)
IL (1) IL198305A0 (enExample)
MX (1) MX2009004522A (enExample)
NZ (1) NZ576591A (enExample)
SG (1) SG175680A1 (enExample)
WO (1) WO2008050356A1 (enExample)
ZA (1) ZA200903173B (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12366585B2 (en) 2006-05-18 2025-07-22 Caris Mpi, Inc. Molecular profiling of tumors
WO2008096375A2 (en) * 2007-02-07 2008-08-14 Decode Genetics Ehf. Genetic variants contributing to risk of prostate cancer
WO2008130009A1 (ja) 2007-04-17 2008-10-30 Santen Pharmaceutical Co., Ltd. 緑内障進行リスクの判定方法
US8697360B2 (en) * 2007-11-30 2014-04-15 Decode Genetics Ehf. Genetic variants on CHR 11Q and 6Q as markers for prostate and colorectal cancer predisposition
WO2009085196A1 (en) * 2007-12-21 2009-07-09 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with prostate cancer risk
CN102144036B (zh) * 2008-07-07 2014-07-16 解码遗传学私营有限责任公司 用于乳腺癌风险评估的遗传变型
EP3216874A1 (en) 2008-09-05 2017-09-13 TOMA Biosciences, Inc. Methods for stratifying and annotating cancer drug treatment options
EP2347009A4 (en) * 2008-10-14 2012-05-30 Caris Mpi Inc GENE AND GENE EXPRESSED TARGET PROTEINS FOR THE PRESENTATION OF BIOMARKERS AND SIGNATURES BY TUMOR TYPE
EP2451975A4 (en) * 2009-05-08 2013-08-14 Decode Genetics Ehf GENETIC VARIANTS CONTRIBUTING TO A RISK OF PROSTATE CANCER
WO2011004404A1 (en) * 2009-07-10 2011-01-13 Decode Genetics Ehf Genetic variants for predicting risk of glaucoma
US20120316218A1 (en) * 2009-07-17 2012-12-13 Glinsky Gennadi V SMALL NON-CODING REGULARTORY RNA's and METHODS FOR THEIR USE
WO2011009089A1 (en) * 2009-07-17 2011-01-20 Ordway Research Institute, Inc. SMALL NON-CODING REGULATORY RNAs AND METHODS FOR THEIR USE
AU2010315601A1 (en) 2009-10-26 2012-05-10 Abbott Laboratories Diagnostic methods for determining prognosis of non-small cell lung cancer
CN102656458B (zh) 2009-10-26 2016-10-19 雅培分子公司 用于测定非小细胞肺癌预后的诊断方法
WO2012029080A1 (en) * 2010-08-30 2012-03-08 Decode Genetics Ehf Sequence variants associated with prostate specific antigen levels
WO2012031207A2 (en) 2010-09-03 2012-03-08 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with prostate cancer risk
US9309556B2 (en) 2010-09-24 2016-04-12 The Board Of Trustees Of The Leland Stanford Junior University Direct capture, amplification and sequencing of target DNA using immobilized primers
US9534256B2 (en) 2011-01-06 2017-01-03 Wake Forest University Health Sciences Methods and compositions for correlating genetic markers with risk of aggressive prostate cancer
EP3483285B1 (en) 2011-02-09 2021-07-14 Bio-Rad Laboratories, Inc. Analysis of nucleic acids
CN102304567B (zh) * 2011-04-29 2013-03-27 广州益善生物技术有限公司 一种染色体8q24区段多态性检测特异性引物和液相芯片
WO2012178058A1 (en) * 2011-06-22 2012-12-27 Indiana University Research And Technology Corporation Compositions for and methods of detecting, diagnosing and prognosing thymic cancer
WO2013065072A1 (en) * 2011-10-30 2013-05-10 Decode Genetics Ehf Risk variants of prostate cancer
EP3024948B1 (en) 2013-07-25 2020-01-15 Bio-rad Laboratories, Inc. Genetic assays for detecting viral recombination rate
JP6883584B2 (ja) * 2015-08-27 2021-06-09 コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. マルチオミック癌プロファイルを用いて機能的な患者固有の体細胞異常を識別するための統合された方法及びシステム
WO2017164699A1 (ko) * 2016-03-24 2017-09-28 서울대학교병원 (분사무소) 전립선암과 관련된 단일염기다형성 및 이를 이용한 유전 위험도 점수의 개발
KR101944927B1 (ko) 2016-03-24 2019-02-07 서울대학교산학협력단 전립선암과 관련된 단일염기다형성 및 이를 이용한 유전 위험도 점수의 개발
CN106480211A (zh) * 2016-11-24 2017-03-08 深圳市核子基因科技有限公司 一种用于检测睾丸癌易感性的试剂盒及其snp标志物
CN110382718A (zh) * 2017-02-01 2019-10-25 法迪亚股份有限公司 用于指示具有特定特征的个体中的前列腺癌的存在或不存在的方法
TW202033760A (zh) * 2018-11-28 2020-09-16 國立大學法人千葉大學 多因素遺傳疾病的基因檢測法、及檢測套件
EP3963092A1 (en) * 2019-05-02 2022-03-09 Predictive Technology Group, Inc. Somatic cancer driver mutations in endometriosis lesions contribute to secondary cancer risk
US20230119558A1 (en) * 2020-03-06 2023-04-20 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Dna damage repair genes in cancer
KR102177218B1 (ko) * 2020-04-24 2020-11-10 유니젠바이오 주식회사 머신러닝 기반 암진단 예측 장치
KR102177222B1 (ko) * 2020-04-24 2020-11-10 유니젠바이오 주식회사 머신러닝 기반 암진단 예측 시스템
KR20250074712A (ko) 2023-11-15 2025-05-28 주식회사 바스젠바이오 전립선암 발병의 위험도를 예측하기 위한 조성물 및 이를 이용한 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5384261A (en) * 1991-11-22 1995-01-24 Affymax Technologies N.V. Very large scale immobilized polymer synthesis using mechanically directed flow paths
AU785425B2 (en) * 2001-03-30 2007-05-17 Genetic Technologies Limited Methods of genomic analysis
US20030170665A1 (en) * 2001-08-04 2003-09-11 Whitehead Institute For Biomedical Research Haplotype map of the human genome and uses therefor
US20040023237A1 (en) * 2001-11-26 2004-02-05 Perelegen Sciences Inc. Methods for genomic analysis
US20040146870A1 (en) * 2003-01-27 2004-07-29 Guochun Liao Systems and methods for predicting specific genetic loci that affect phenotypic traits

Similar Documents

Publication Publication Date Title
JP2010507388A5 (enExample)
JP2011530306A5 (enExample)
JP2010527603A5 (enExample)
Zhang et al. Comprehensive one-step molecular analyses of mitochondrial genome by massively parallel sequencing
JP2010520745A5 (enExample)
Coulombe-Huntington et al. Fine-scale variation and genetic determinants of alternative splicing across individuals
Antoniadi et al. Application of targeted multi-gene panel testing for the diagnosis of inherited peripheral neuropathy provides a high diagnostic yield with unexpected phenotype-genotype variability
JP2010533477A5 (enExample)
JP2010522555A5 (enExample)
JP2010518848A5 (enExample)
CA2511042A1 (en) Association of single nucleotide polymorphisms in ppar.gamma. with osteoporosis
JP2011520433A5 (enExample)
JP2017529859A (ja) 乳癌発症リスクを評価する方法
EP3332031B1 (en) Snp rs12603226 as a predictive marker for nafld
RU2016131167A (ru) Способы лечения, диагностики и мониторинга волчанки
JP2010510804A5 (enExample)
TW202438680A (zh) 可實施2種以上檢測的遺傳學分析方法
KR101536213B1 (ko) 복부비만 예측용 snp 마커 및 이의 용도
JP5721150B2 (ja) 加齢黄斑変性症の発症リスクの予測方法
Huang et al. Copy number variations are a rare cause of non-CMT1A Charcot-Marie-Tooth disease
KR101532308B1 (ko) 복부비만 예측용 snp 마커 및 이의 용도
CN109182490B (zh) Lrsam1基因snp突变位点分型引物及其在冠心病预测中的应用
US20160053333A1 (en) Novel Haplotype Tagging Single Nucleotide Polymorphisms and Use of Same to Predict Childhood Lymphoblastic Leukemia
KR102346185B1 (ko) 피부 색소 침착 위험도 예측용 바이오마커 및 이의 용도
JP2008505060A5 (enExample)